Objective: Historically, changes in normal thyroid uptake values for iodine have been reported in different geographical areas. These changes have been linked to geographical and chronological fluctuations in dietary iodine intake in different populations. Namibia is a country with mixed ethnicity, with access to dietary iodine in table salt. Despite historical reports on deviating normal thyroid uptake values (emphasising the importance of establishing local normal reference values), the relevant Namibian authorities have never revised these reference values, nor have local reference values been established. The aim of this study was to establish the normal reference values for thyroid uptake of technetium-99m pertechnetate in the Namibian population.
Introduction
The normal reference values for thyroid uptake of technetium-99m pertechnetate and radioactive iodine in euthyroid persons change with the geographical location, and may change from one decade to the next. Throughout history, fluctuations in the normal reference values have been documented. These reports show the importance of periodic evaluation of normal reference values for thyroid uptake. Bernard et al 1 discovered that the uptake range found in normal subjects deviated significantly from the traditional radioactive iodine ranges that were routinely used.
In California, Blum and Chandra 2 Normal reference values for thyroid uptake of technetium-99m pertechnetate for the Namibian population important to establish normal thyroid uptake values on a regional basis, since normal limits vary within different geographical areas, 6 according to Nelson et al.
Geographical location-specific reference data for thyroid uptake of technetium-99m pertechnetate are rare and vary significantly. [7] [8] [9] Therefore, there is a need to establish reference values for each location.There are no reported reference values for technetium-99m pertechnetate uptake for Namibia. The reference range routinely used in Namibia for thyroid uptake of technetium-99m pertechnetate is 0.75-4% of the administered activity after 20 minutes. This range was adopted from guidelines of the International Society of Nuclear Medicine 10 as it is not always convenient for each nuclear medicine facility to determine technetium-99m pertechnetate uptake in normal euthyroid individuals.
This study was limited to the Khomas region as it was the only region in Namibia that had a nuclear medicine department at the time of the research study which was from August to December 2011. The present study sought to test the hypothesis that thyroid uptake reference values for technetium-99m pertechnetate in the Namibian population deviate from available international normal reference values.
Euthyroid individuals were identified to determine a normal reference range for thyroid uptake of technetium-99m pertechnetate for the Namibian population. A normative or norm-referenced research design was used which focused on establishing the normal reference values for specific variables to serve as a guide for diagnosis and treatment planning. A cross-sectional approach, which focused on a small subpopulation at one point in time in order to draw conclusions about the whole population, was adopted. Furthermore, a prospective data collection method was used to record the research variables. The study was non-therapeutic, and the participants received very low doses of ionising radiation.
Method
Seventy-six participants (58 women and 18 men), ranging in age from 39-81 years, living in the Khomas region of Windhoek, Namibia, were recruited. Three sampling methods, namely purposive, nonprobability and snowball sampling, were used. Each subject was selected by using a questionnaire which evaluated the clinical history, history of iodinated-contrast radiographic procedures and a physical examination, to exclude those with cardiac, renal or thyroid disease. Individuals with iodine contamination were also excluded. Participants taking medication known used. Images were obtained on a 128 × 128 pixel matrix, with a zoom of 1.8. Images of the syringe were obtained before and after injection of technetium99m pertechnetate to determine the exact amount of administered activity for the calculation of thyroid uptake. Images of the syringe and anterior neck were acquired for 60 seconds. A control image of the injection site was obtained to determine if there was any extravasation that would invalidate the thyroid uptake percentage calculation.
The total number of counts was calculated by drawing an irregular region of interest (yellow) around the borders of the thyroid gland ( Figure 1a) . A rectangular region of interest (red), with a width that was approximately equal to that of the thyroid gland, was drawn under the gland to represent the background ( Figure 1a ). To demonstrate that the thyroid could be visualised at very low uptake, and that the respective images were of acceptable quality, an image that corresponded with an uptake of 0.25% was obtained (Figure 1b ).
Pre-injection syringe counts (F) and the post-injection syringe counts (E) were obtained from the images. All counts were corrected for the decay of technetium99m pertechnetate and acquisition time.
The thyroid uptake of technetium-99m pertechnetate for each participant was calculated using the following formula:
where TH and BK are the thyroid and background counts, respectively.
Results
The study comprised 76 research participants (58 women and 18 men). Only participants aged 39 years and older were included in the study because of radiation safety concerns. Participants were selected from a population of mixed ethnicity consisting of Hereros, Ovambos, Damaras, Namas, Coloureds, Caucasians and other non-Namibian immigrants. The ethnic distribution of the 76 participants, as illustrated in Figure 2 , included 40.8% (n = 31) Ovambos, 23.7 % (n = 18) Hereros, 14.5% (n = 11) , 7.9% (n = 6) Namas, 6.6% (n = 5) Damaras, 5.2% (n = 4) Caucasians, and 1.3% (n = 1) others.
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The questionnaire comprised two sections on medical history and source of dietary iodine. Analysis of the medical history noted that participants had no past thyroid disorders, and were not suspected of having any thyroid disorders at the time of the study. Participants were not exposed to iodinated contrast media or radionuclides prior to or during the investigation. None of them had a history of taking heart medication two years before the study. None of the female participants had used any iodine-containing vaginal douche, or were pregnant or nursing at the time of investigation. None of the participants were smokers.
The different ethnic groups followed unique diets. All of the participants used iodised Twenty of the participants took energy supplements on a daily basis. These supplements did not contain high levels of iodine, and were found to contribute less than the daily recommended intake of 0.25 mg. All of the participants consumed fresh milk in their tea or coffee on a daily basis. Cheese, yoghurt, ice cream, frozen yoghurt and eggs were only eaten occasionally. All of the participants consumed at least two slices of bread daily. From an analysis of the dietary iodine section of the questionnaire, it emerged that the main sources of dietary iodine for this population were iodised table salt, dairy products and bread.
No enlarged thyroid glands or nodules were palpated on clinical evaluation of the 76 euthyroid participants. These findings were further confirmed by scintigraphic images which did not show thyromegally or nodules. The results of the serum thyroid hormone levels are summarised in Table I . All levels of thyroid hormones were within normal ranges.
The thyroid uptake of technetium-99 m pertechnetate ranged from 0.15-2.14%. The characteristics of the 76 euthyroid participants at the Windhoek Central Hospital's Department of Nuclear Medicine are summarised in Table II . The mean [± standard deviation (SD)] technetium-99m pertechnetate uptake for males and females was 0.65 ± 0.38 and 0.81± 0.47%, respectively. When combined, the average pertechnetate uptake in the study cohort was 0.78 ± 0.45%. The gender-specific data were compared to the whole euthyroid research population, as illustrated in Figure  3 . The data show that gender did not seem to play a significant role in euthyroid pertechnetate uptake, but normal values appeared to be marginally lower in men (0.65 ± 0.38%) than in women (0.81 ± 0.47%). To test whether or not ethnicity played a role in euthyroid uptake of technetium-99m pertechnetate, ethnic uptake data were compared with those pertaining to the population (Figure 4) . No significant differences were apparent among the ethnic groups, relative to the representative population.
To determine if technetium-99m pertechnetate uptake was normally distributed in the Namibian population, uptake values were grouped over intervals of 0.25% The red bars represent participants with uptake values less than the departmental lower limit of 0.75%
Owing to skewness in uptake distribution, the 95% confidence interval and the mean (± SD) were considered to be inappropriate indicators of the normal reference range. To determine the reference range for technetium-99m pertechnetate, the data in Figure 5 were plotted as a cumulative frequency curve, as presented in Figure 6 . The fifth and 95 th percentiles were then determined to represent the normal reference range for the Namibian population.
The fifth and 95 th percentiles were found to be in the range of 0.15-1.69%.
Discussion
In this study, the range of euthyroid uptake of derived technetium-99m pertechnetate differed significantly from the internationally accepted normal reference values (0.75-4%) that are currently used by the Department of Nuclear Medicine of the Windhoek Central Hospital, Namibia. In this study, the reference uptake values were found to range from 0.15-1.69%. The data in Figure 5 demonstrate that as many as 50% of participants had uptake values below 0.75%. Furthermore, approximately half of these presented with a very low uptake of ≤ 0.50%. On the basis of the departmental reference values, these participants would have been diagnosed as abnormal. Although these data overlap considerably with other ranges reported elsewhere, [7] [8] [9] they differ significantly. From the current findings, gender, age and ethnicity did not appear to significantly influence euthyroid uptake of technetium-99m pertechnetate. The reasons for the extremely low pertechnetate uptake values encountered in this study are not clear, but may relate to diet and dietary supplementation. Vitamins and minerals taken by participants in this study did not contain high levels of iodine. However, the continuous intake of iodised table salt could have reduced thyroid uptake of technetium-99m pertechnetate. This notion is supported by the fact that thyroid uptake of iodine directly correlates with technetium-99m pertechnetate uptake, 18 implying that the mode by which the two radiochemicals are taken up by the thyroid is similar. In an earlier study, Reinhardt et al 19 demonstrated that thyroid uptake of pertechnetate inversely correlated with iodine intake, suggesting that preloading the thyroid with cold iodine can significantly reduce the subsequent uptake of technetium-99m pertechnetate. Therefore, it is not surprising that thyroid uptake pertechnetate tended to be low in a population that supplemented its diet with the daily intake of iodised salt.
Conclusion
There was a marked lowering of normal thyroid uptake values for technetium-99m pertechnetate in Namibia, compared to those that are traditionally used in the clinic. It is recommended that these new reference values are used for the Namibian population. The data obtained in this study provide new evidence that emphasises the importance of periodic, locationspecific monitoring of thyroid uptake of technetium99m pertechnetate to maintain quality assurance.
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